Header Logo

Connection

ALASTAIR THOMPSON to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Protein Kinase Inhibitors.
ALASTAIR THOMPSON
Connection Strength
0.028
Protein Kinase Inhibitors
  1. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int J Cancer. 2009 Jan 15; 124(2):465-72.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.